Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02859415
Brief Title: Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases

First Submitted : August 6, 2016
First Submitted that Met QC Criteria : August 6, 2016
First Posted : August 9, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 9, 2021
Last Update Posted : January 12, 2021